IV M1-c6v1 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug called M1-c6v1 given through an IV for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it's safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced or metastatic solid tumors that haven't responded to standard treatments or you couldn't take them.
- You need at least one tumor that can be measured on a scan.
- You should be in generally good health (able to do daily activities) and expected to live at least 12 more weeks.
- You must not have a weakened immune system or be taking immune-suppressing drugs.
- You cannot have had any cancer treatment in the past 4 weeks (except for some mild steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a virus called M1 (VRT106) that may be able to infect and destroy cancer cells. It's given by injection directly into a tumor, and is for people whose advanced solid tumors haven't responded to other treatments.
This Phase 1/2 trial tests IMP9064, either alone or with another treatment, in people with advanced solid cancers that have stopped responding to standard care. It aims to see how well it works and how safe it is, including whether it can be used when treatment options are limited.
This study tests a new oral drug, GIM-531, alone and in combination with an anti-PD-1 therapy for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and effective.
This trial tests an intravenous virus treatment (VRT106) for people with advanced solid tumors that have stopped responding to standard therapies. The goal is to see if the virus can target and help control the cancer.
This trial tests a combination of two experimental drugs, IMM2510 and IMM01, in people with advanced solid tumors that have not responded to other treatments. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests an experimental drug called IMC-001 for people whose cancer has spread or is locally advanced and has a high number of genetic mutations (TMB-H). The drug aims to help the immune system fight cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.